1373243-73-2

Upstream product

• 1373243-13-0 1'-(4-fluorobenzyl)-6-hydroxy-2H-spiro [benzofuran-3,3'-indolin]-2'-one 
• 1373243-10-7 1-(4-fluorobenzyl)-3-hydroxy-3-(2-hydroxy-4-methoxyphenyl)indolin-2-one 
• 1373241-89-4 C₂₉H₂₆FNO₄ 
• 1373241-87-2 C₂₈H₂₄FNO₄ 
• 1373241-86-1 C₂₈H₂₂FNO₄ 
• 1373243-12-9 1'-(4-fluorobenzyl)-6-methoxy-2H-spiro[benzofuran-3,3'-indolin]-2'-one 
• 1373243-11-8 1-(4-fluorobenzyl)-3-(2-hydroxy-4-methoxyphenyl)indolin-2-one 
• 1373243-14-1 5-acetyl-1'-(4-fluorobenzyl)-6-hydroxy-2H-spiro[benzofuran-3,3'-indolin]-2'-one 
• 313245-18-0 (1-(4-fluoro-benzyl)-1H-indole-2,3-dione) 
• 91-56-5 indole-2,3-dione 
• 459-46-1 4-Fluorobenzyl bromide 

Relevant academic research and scientific papers

SPIROCYCLIC COMPOUNDS AS VOLTAGE-GATED SODIUM CHANNEL MODULATORS

The present invention relates to compounds of Formula (I) along with processes for their preparation that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions modulated by VGSCs. The invention further relates to methods of treating, preventing managing and/or lessening the diseases, disorders, syndromes or conditions by modulators of VGSC of Formula (I).